A Food Effect Study of SPH5030 Tablets.
The purpose of this study is to evaluate the food effect of SPH5030 tablets in healthy Chinese adult subjects.
Advanced Solid Tumor
DRUG: SPH5030|DRUG: SPH5030
Peak Plasma Concentration (Cmax), PK（Pharmacokinetics）, Approximately 2 months|Peak time（Tmax）, PK（Pharmacokinetics）, Approximately 2 months|Area under the plasma concentration versus time curve (AUC), PK（Pharmacokinetics）, Approximately 2 months
Incidence of Treatment-Emergent Adverse Events, Adverse event type, incidence, duration, Approximately 2 months
The purpose of this study is to evaluate the food effect of SPH5030 tablets in healthy Chinese adult subjects.